At Triptherapie, we prefer psilocybin mushrooms over
ayahuasca for several reasons. Firstly, psilocybin mushrooms, or magic truffles, are legal in the Netherlands, making them more accessible for therapeutic use. In contrast, ayahuasca and its active component
DMT is illegal in many countries, including the Netherlands, which complicates their use in therapeutic settings.
Secondly,
psilocybin allows for a degree of control during the experience. While a light psilocybin trip can be somewhat guided, ayahuasca experiences are often less controllable, which can be overwhelming for some individuals, particularly those who may struggle with anxiety or a need for control. A high dose of magic mushrooms can be just as intense as ayahuasca or even more that that.
Thirdly, the absence of MAO inhibitors (MAOIs) in psilocybin sessions means that there are fewer risks of complications associated with dietary restrictions and interactions that are necessary when consuming ayahuasca. This makes psilocybin a safer option for many individuals.
Rresearch from institutions like the Johns Hopkins School of Medicine has shown a growing interest in psilocybin for therapeutic applications, particularly in treating conditions such as depression and anxiety. This scientific backing further supports our preference for psilocybin mushrooms as a therapeutic tool.
In summary, the legal status, controllability of the experience, safety profile, and scientific research supporting psilocybin's efficacy contribute to our preference for psilocybin mushrooms over ayahuasca in therapeutic settings.
